Agit en es it fr

Agit Brand names, Agit Analogs

Agit Brand Names Mixture

  • No information avaliable

Agit Chemical_Formula

C33H37N5O5

Agit RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Agit fda sheet

Agit FDA

Agit msds (material safety sheet)

Agit MSDS

Agit Synthesis Reference

No information avaliable

Agit Molecular Weight

583.678 g/mol

Agit Melting Point

No information avaliable

Agit H2O Solubility

No information avaliable

Agit State

Solid

Agit LogP

No information avaliable

Agit Dosage Forms

Liquid

Agit Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Agit Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Agit Absorption

Interpatient variable and may be dependent on the administration technique

Agit side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Agit Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45 (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Agit Organisms Affected

Humans and other mammals